From: Impact of anemia on in-stent restenosis after percutaneous coronary intervention
Variable | Anemia | P value | Without anemia | P value | ||
---|---|---|---|---|---|---|
ISR | Non-ISR | ISR | Non-ISR | |||
Male, n (%) | 14 (3.7) | 133 (34.6) | 0.524 | 4 (1.0) | 233 (60.7) | 0.097 |
Age (years) | 67.1 ± 10.9 | 62.4 ± 11.2 | 0.094 | 54.3 ± 10.4 | 62.1 ± 9.6 | 0.012 |
Current smoker, n (%) | 7 (3.0) | 81 (34.8) | 0.457 | 5 (2.1) | 140 (60.1) | 0.525 |
BMI (kg/m2) | 23.5 ± 3.7 | 24.6 ± 2.8 | 0.120 | 24.3 ± 2.7 | 24.4 ± 2.8 | 0.841 |
Hypertension, n (%) | 10 (2.9) | 106 (30.5) | 0.367 | 7 (2.0) | 224 (64.6) | 0.696 |
Diabetes mellitus, n (%) | 11 (9.7) | 31 (27.4) | 0.000 | 0 (0.0) | 71 (62.9) | 0.221 |
LDL-c (mmol/L) | 2.9 ± 1.5 | 2.5 ± 0.9 | 0.687 | 3.6 ± 1.9 | 2.6 ± 0.9 | 0.087 |
TG (mmol/L) | 1.3 ± 0.4 | 1.6 ± 1.0 | 0.397 | 1.8 ± 0.8 | 1.6 ± 0.9 | 0.576 |
Hb (g/dL) | 104.8 ± 15.7 | 111.4 ± 14.6 | 0.072 | 134.4 ± 10.8 | 145.8 ± 13.8 | 0.011 |
LVEF (%) | 56.5 ± 6.8 | 60.2 ± 5.8 | 0.013 | 59.3 ± 9.8 | 59.9 ± 6.9 | 0.777 |
CKD (%) | 8 (11.9) | 23 (34.3) | 0.001 | 0 (0.0) | 36 (53.8) | 0.607 |
ACS (%) | 11 (3.7) | 85 (28.8) | 0.519 | 4 (1.4) | 195 (66.1) | 0.352 |
Multiple stenting, n (%) | 9 (5.8) | 42 (26.9) | 0.035 | 5 (3.2) | 100 (64.1) | 0.142 |
Stent length (mm) | 28.8 ± 6.5 | 29.7 ± 5.1 | 0.463 | 28.8 ± 5.6 | 29.5 ± 5.6 | 0.695 |
Stent diameter (mm) | 2.9 ± 0.5 | 3.2 ± 0.5 | 0.024 | 3.0 ± 0.4 | 3.2 ± 0.5 | 0.262 |
Multivessel coronary disease (%) | 4 (3.9) | 23 (22.5) | 0.484 | 2 (2.0) | 73 (51.6) | 1.000 |
LMCA, n (%) | 1 (8.3) | 2 (16.7) | 0.275 | 1 (8.3) | 8 (66.7) | 0.226 |
LAD, n (%) | 4 (4.9) | 13 (15.9) | 0.075 | 3 (3.7) | 62 (75.6) | 0.396 |
LCX, n (%) | 14 (5.6) | 72 (29.0) | 0.008 | 4 (1.6) | 158 (63.8) | 1.000 |
RCA, n(%) | 4 (1.9) | 68 (32.5) | 0.129 | 3 (1.4) | 134 (64.2) | 0.748 |
Bifurcation lesion, n (%) | 10 (7.2) | 30 (21.7) | 0.000 | 3 (2.2) | 95 (68.9) | 1.000 |
Calcification, n (%) | 2 (7.4) | 9 (33.3) | 0.307 | 2 (7.4) | 14 (51.9) | 0.068 |
Statins, n (%) | 18 (3.5) | 152 (29.9) | 0.332 | 8 (1.6) | 331 (65.0) | 0.053 |
Aspirin, n (%) | 18 (3.4) | 154 (29.1) | 0.403 | 10 (1.9) | 348 (65.6) | 0.811 |
Clopidogrel, n (%) | 9 (3.4) | 83 (31.0) | 0.880 | 6 (2.2) | 170 (63.4) | 0.476 |
Ticagrelor, n (%) | 6 (2.5) | 67 (28.3) | 0.485 | 4 (1.7) | 160 (67.5) | 0.760 |